Companies: 10,795·Total market cap: $144.5T
Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

AMPHNASDAQHealthcare● Active
$19.53
$-0.21(-1.08%)
Market Cap$861002429
P/E Ratio
52W High$31.26
52W Low$16.65

Amphastar Pharmaceuticals, Inc.(AMPH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AMPH · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.72B$0.73B$0.64B$0.50B$0.44B
Cost of Revenue$0.36B$0.36B$0.29B$0.25B$0.24B
Gross Profit$0.36B$0.37B$0.35B$0.25B$0.20B
Gross Margin %(computed)49.46%51.08%54.49%49.87%45.63%
Operating Expenses
R&D Expenses$0.09B$0.07B$0.07B$0.07B$0.06B
G&A Expenses$0.09B$0.06B$0.05B$0.05B$0.05B
Total Operating Expenses$0.22B$0.17B$0.15B$0.14B$0.13B
Operating Income$0.14B$0.21B$0.20B$0.11B$0.07B
Operating Margin %(computed)19.50%28.06%30.57%21.54%15.96%
Interest Income$0.01B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.03B$0.03B$0.03B$0.00B$0.00B
Income Before Tax$0.12B$0.19B$0.17B$0.11B$0.08B
Income Tax Expense$0.03B$0.03B$0.03B$0.02B$0.02B
Net Income$0.10B$0.16B$0.14B$0.09B$0.06B
Net Margin %(computed)13.63%21.79%21.34%18.31%14.19%
Per Share & EBITDA
EPS (Basic)$2.10$3.29$2.85$1.88$1.30
Wtd Avg Shares0.05B0.05B0.05B0.05B0.05B
EBITDA$0.15B$0.28B$0.24B$0.15B$0.11B
EBITDA Margin %(computed)20.71%37.89%37.29%29.29%25.48%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Amphastar Pharmaceuticals, Inc.

关于Amphastar Pharmaceuticals, Inc.(AMPH)损益表

Amphastar Pharmaceuticals, Inc.(AMPH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,AMPH实现营收$0.72B,毛利润$0.36B(毛利率49.46%),净利润$0.10B(净利率13.63%)。

常见问题

AMPH · 4 问

Amphastar Pharmaceuticals, Inc.(AMPH)2025财年营收为$0.72B,同比down1.7%。

AMPH revenueAMPH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08